Provided is use of an oxygen-enriched water composition comprising water and oxygen, in the manufacture of a medicament for treatment and/or prevention of hyperuricemia wherein: (a) the oxygen-enriched water composition comprises an oxygen content of no less than 20 ppm when the oxygen content of the oxygen-enriched water composition is measured at a temperature ranging from 4 oC to 50 oC； and (b) the oxygen content of the oxygen-enriched water composition has a temporal stability that is characterized by the following feature: provided that the oxygen content measured at a given time point t0 is 100%, the oxygen content measured at 30 minutes from the given time point t0 is A%, and the oxygen content measured at 180 minutes from the given time point t0 is B%, then a difference between A% and B% is less than 24%.
